ORGANOGENESIS HOLDINGS INC. Increase (Decrease) in Security Deposits
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Increase (Decrease) in Security Deposits of $263.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInSecurityDeposits · last filed 2022-03-01
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in security deposits for the quarter ending 2019-12-31 was -$526.00K.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in security deposits for the quarter ending 2019-09-30 was $0.00.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in security deposits for the quarter ending 2019-06-30 was $0.00.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in security deposits for the quarter ending 2019-03-31 was $263.00K.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in security deposits for fiscal 2020 was $263.00K.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in security deposits for fiscal 2019 was -$263.00K.
| Period end | Increase (Decrease) in Security Deposits 1 month | Increase (Decrease) in Security Deposits 3 month | Increase (Decrease) in Security Deposits 6 month | Increase (Decrease) in Security Deposits 9 month | Increase (Decrease) in Security Deposits 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $263.00K 10-K · filed 2021-03-16 | ||||
| 2019-12-31 | -$526.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$526.00K derived: sum of 2 quarters · filed 2020-03-09 | -$526.00K derived: sum of 3 quarters · filed 2020-03-09 | -$263.00K 10-K · filed 2020-03-09 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $263.00K 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $263.00K 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | $263.00K 10-K · filed 2022-03-01 | $263.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |